NCT05908591 Sleep Disordered Breathing, Endothelial Function, and Adverse Events in Pregnancy
| NCT ID | NCT05908591 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Pregnancy Related |
| Study Type | OBSERVATIONAL |
| Enrollment | 109 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2027-04-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 109 participants in total. It began in 2023-01-01 with a primary completion date of 2027-04-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective longitudinal cohort study whereby pregnant individuals are asked to complete an 8-day testing protocol to measure their sleep and cardiovascular health at two timepoints during pregnancy.
Eligibility Criteria
Inclusion Criteria: * over 18 years of age * pregnant (20-24 weeks gestation at enrollment) Exclusion Criteria: * worked shift work past 11pm in the previous month * previously diagnosed with a sleep disorder by a physician
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05908591 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05908591 currently recruiting?
Yes, NCT05908591 is actively recruiting participants. Contact the research team at mdavenpo@ualberta.ca for enrollment information.
Where is the NCT05908591 trial being conducted?
This trial is being conducted at Edmonton, Canada.
Who is sponsoring the NCT05908591 clinical trial?
NCT05908591 is sponsored by University of Alberta. The trial plans to enroll 109 participants.